Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000214593 | SCV000113863 | benign | not specified | 2015-07-01 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000214593 | SCV000268849 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Val1114Met in exon 20 of CCDC40: This variant is not expected to have clinical s ignificance because it has been identified in 10.8% (13/120) of Colombian chromo somes from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.n ih.gov/projects/SNP; dbSNP rs61740509). |
Prevention |
RCV000214593 | SCV000313103 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000266556 | SCV000407225 | likely benign | Primary ciliary dyskinesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000379558 | SCV000483686 | likely benign | Glycogen storage disease, type II | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000266556 | SCV000558507 | benign | Primary ciliary dyskinesia | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001126068 | SCV001285221 | benign | Primary ciliary dyskinesia 15 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV001705773 | SCV001887186 | benign | not provided | 2018-07-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000266556 | SCV002606640 | benign | Primary ciliary dyskinesia | 2016-08-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001705773 | SCV005214217 | likely benign | not provided | criteria provided, single submitter | not provided |